Leidos CFO reports dividend-equivalent stock credit in Form 4

Leidos Holdings, Inc. Chief Financial Officer Christopher R. Cage reported a routine change in his ownership of company stock.

Rhea-AI Filing Summary

Leidos Holdings, Inc. Chief Financial Officer Christopher R. Cage reported a routine change in his ownership of company stock. On 12/31/2025, he acquired 58.8718 shares of Leidos common stock at a price of $0, credited through dividend equivalent rights under the company’s Key Executive Stock Deferral Plan. After this transaction, he beneficially owned 29,401.5352 shares indirectly through the deferral plan and 46,680 shares directly of Leidos common stock. The filing characterizes the acquisition as based on dividend equivalent rights, which means cash dividends are credited in the form of additional stock units rather than cash.

Insider Trade Summary

Grant/Award: 58.8718 shares

Grant/Award 2 txns

Insider Cage Christopher R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	58.8718	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 29,401.5352 shares (Indirect, By Key Executive Stock Deferral Plan); Common Stock — 46,680 shares (Direct)

Footnotes (1)

1. F1. Dividend equivalent rights.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Leidos (LDOS) report in this Form 4?

The Form 4 reports that Chief Financial Officer Christopher R. Cage acquired 58.8718 shares of Leidos common stock on 12/31/2025 at a price of $0, credited under the company’s Key Executive Stock Deferral Plan.

How many Leidos (LDOS) shares does the CFO own after this transaction?

After the reported transaction, Christopher R. Cage beneficially owned 29,401.5352 shares indirectly through the Key Executive Stock Deferral Plan and 46,680 shares directly of Leidos common stock.

What is the nature of the 58.8718 Leidos (LDOS) shares acquired by the CFO?

The 58.8718 shares reported as acquired on 12/31/2025 are described as dividend equivalent rights, meaning dividends were credited in the form of additional stock units rather than cash.

Was the Leidos (LDOS) insider transaction a purchase for cash?

No. The transaction shows the CFO acquired 58.8718 shares at a price of $0, indicating the shares were credited through dividend equivalent rights under a compensation plan, not bought on the open market.

How are the CFO’s Leidos (LDOS) shares held according to the Form 4?

The Form 4 shows 29,401.5352 shares held indirectly through the Key Executive Stock Deferral Plan and 46,680 shares held directly by Christopher R. Cage.

What role does Christopher R. Cage have at Leidos (LDOS)?

Christopher R. Cage is identified as an Officer of Leidos Holdings, Inc., serving as the company’s Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/02/2026 - 05:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cage Christopher R

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/31/2025		A		58.8718(1)	A	$0	29,401.5352	I	By Key Executive Stock Deferral Plan
Common Stock								46,680	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Dividend equivalent rights.

Remarks:

	/s/ Ramune M. Kligys by PoA of Christopher R. Cage	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.